Publication | Closed Access

The novel glycyrrhetinic acid–tetramethylpyrazine conjugate TOGA induces anti-hepatocarcinogenesis by inhibiting the effects of tumor-associated macrophages on tumor cells

Tumor-associated MacrophagesMedicineLiver PhysiologyPharmacologyCancer Cell BiologyTumor CellsHepatotoxicityAnti-cancer AgentOncologyRadiation OncologyCancer ResearchTumor BiologyHealth Sciences